Cellectis (CLLS) Cash & Equivalents Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.90% |
| Dec 31, 2025 | -23.90% |
| Sep 30, 2025 | -11.30% |
| Jun 30, 2025 | -29.38% |
| Mar 31, 2025 | -14.97% |
| Dec 31, 2024 | -15.90% |
| Sep 30, 2024 | -16.78% |
| Jun 30, 2024 | -21.25% |
| Mar 31, 2024 | -20.16% |
| Dec 31, 2023 | -21.25% |
| Sep 30, 2023 | -27.82% |
| Jun 30, 2023 | -29.11% |
| Mar 31, 2023 | -20.09% |
| Dec 31, 2022 | -18.32% |
| Sep 30, 2022 | -18.03% |
| Jun 30, 2022 | -12.65% |
| Mar 31, 2022 | -9.46% |
| Dec 31, 2021 | -6.57% |
| Sep 30, 2021 | -9.24% |
| Jun 30, 2021 | -6.91% |
| Mar 31, 2021 | -7.00% |
| Dec 31, 2020 | -6.88% |
| Sep 30, 2020 | 15.87% |
| Jun 30, 2020 | 22.36% |
| Mar 31, 2020 | 17.73% |
| Dec 31, 2019 | 104.82% |